HIV/AIDS Vaccine
Scientists at AIDS Center report research in HIV/AIDS vaccine
Published in AIDS Weekly, March 22nd, 2010
Scientists discuss in 'The preventive phase I trial with the HIV-1 Tat-based vaccine' new findings in HIV/AIDS vaccine. "The native HIV-1 Tat protein was chosen as vaccine candidate for phase I clinical trials based on its role in the natural infection and AIDS pathogenesis, on the association of Tat-specific immune response with the asymptomatic stage as well as on its sequence conservation among HIV clades. A randomized, double blind, placebo-controlled phase I study (ISS P-001) was conducted in healthy adult volunteers without identifiable risk of HIV infection," scientists writing in the journal Vaccine report.
"Tat was administered 5 times monthly, subcute...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-03-22)
More Articles from AIDS Weekly
- University of Montreal
How to fortify the immunity of HIV patients - Antiretrovirals
Study findings from University of Barcelona provide new insights into antiretrovirals - Central Nervous System Disease
New research on central nervous system disease from N. Venhoff and co-authors summarized - Clinical Trial Research
Research from Population Council in the area of clinical trial research described - Drug Development
New findings in drug development described from Shanghai Jiao Tong University - HIV/AIDS
Data from W. Manosuthi et al provide new insights into HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
